Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000863964 | SCV000514960 | likely benign | not provided | 2019-02-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000863964 | SCV001004700 | likely benign | not provided | 2024-10-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002524808 | SCV003742035 | uncertain significance | Inborn genetic diseases | 2021-05-21 | criteria provided, single submitter | clinical testing | The c.509-5T>C intronic alteration consists of a T to C substitution 5 nucleotides before coding exon 6 in the TPP1 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004554769 | SCV004771283 | likely benign | TPP1-related disorder | 2022-11-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |